AbbVie, Amgen and Takeda jointly study impact of anti-inflammatory drugs in COVID-19 treatment EP News Bureau Aug 4, 2020 I-SPY COVID will evaluate the impact of cenicriviroc, otezla, and firazyr on inflammatory response in severely ill, hospitalised…
Cipla receives final approval for generic version of Shire’s Firazyr EP News Bureau Jul 14, 2020 Icatibant injection is indicated for the treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and…
